首页> 外文OA文献 >Structure-Based Discovery of ABCG2 Inhibitors: A Homology Protein-Based Pharmacophore Modeling and Molecular Docking Approach
【2h】

Structure-Based Discovery of ABCG2 Inhibitors: A Homology Protein-Based Pharmacophore Modeling and Molecular Docking Approach

机译:基于结构的ABCG2抑制剂的发现:一种同源性蛋白质的药物模型和分子对接方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

ABCG2 is an ABC membrane protein reverse transport pump, which removes toxic substances such as medicines out of cells. As a result, drug bioavailability is an unexpected change and negatively influences the ADMET (absorption, distribution, metabolism, excretion, and toxicity), leading to multi-drug resistance (MDR). Currently, in spite of promising studies, screening for ABCG2 inhibitors showed modest results. The aim of this study was to search for small molecules that could inhibit the ABCG2 pump. We first used the WISS MODEL automatic server to build up ABCG2 homology protein from 655 amino acids. Pharmacophore models, which were con-structed based on strong ABCG2 inhibitors (IC50 < 1 μM), consist of two hydrophobic (Hyd) groups, two hydrogen bonding acceptors (Acc2), and an aromatic or conjugated ring (Aro|PiR). Using molecular docking method, 714 substances from the DrugBank and 837 substances from the TCM with potential to inhibit the ABCG2 were obtained. These chemicals maybe favor synthesized or extracted and bioactivity testing.
机译:ABCG2是ABC膜蛋白逆转输送泵,其除去诸如药物之类的毒性物质,从细胞中除外。结果,药物生物利用度是一种意想不到的变化,负面影响备用电池(吸收,分布,新陈代谢,排泄和毒性),导致多毒性(MDR)。目前,尽管有希望的研究,ABCG2抑制剂的筛查表现出适度的结果。本研究的目的是寻找可能抑制ABCG2泵的小分子。我们首先使用Wiss Model自动服务器,从655个氨基酸构建ABCG2同源蛋白。基于强ABCG2抑制剂(IC50 <1μm)的药镜模型,由两个疏水(IC50 <1μm)组成,包括两个疏水性(HYD)基团,两个氢键受体(ACC2)和芳族或共轭环(ARO | PIR)。使用分子对接方法,获得来自药物银行的714种来自TCM的837种具有抑制ABCG2的物质。这些化学品可能有利于合成或提取的和生物活性测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号